Delivery Order SPE2DB22D1103-SPE2DB24FTGC2
Award Date 3/5/24
Potential Completion Date 3/6/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $36,817.54 to AmerisourceBergen Drug Corp for the supply of VRAYLAR 1.5 MG CAPSULE 30S. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical commodities to support military treatment...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $10,793.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VRAYLAR 1.5 MG CAPSULE 30S. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,259,825 units of the pharmaceutical product VRAYLAR 1.5 MG CAPSULE 30S. The contract has a ceiling value of $5,226.62 and a completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is part of a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 6 MG CAPSULE 30S. The delivery order has a potential value of $5,313.66 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The $4,426.60 contract has a performance period through March 5, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of VRAYLAR 1.5 MG CAPSULE 30S. The contract, valued at $3,791.54, has an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,582.61 to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This delivery order contract falls under a larger indefinite delivery contract (IDC) previously awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $10,529.83 firm fixed price delivery order contract to provide VRAYLAR 3 MG CAPSULE 30S, a specialty pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,568.07 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This delivery...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a Firm Fixed Price Delivery Order contract worth $10,422.67 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a neurological medication, with a completion date of July 18, 2025. This contract is not a set-aside and is part of AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...